AVT NATURAL PRODUCTS LTD. Q1 FY27 Results

AVT Natural Products' consolidated Q1 FY27 (quarter ended June 30, 2026) print was strong on a year-on-year basis: revenue rose 82.2% to ₹241.21 Cr (₹132.42 Cr a year ago) and consolidated PAT more than doubled, up 156.7% to ₹31.10 Cr (₹12.12 Cr), with EPS at ₹2.04 versus ₹0.80. Sequentially, revenue grew a more modest 6.5% and PAT 41.2% over Q4 FY26 (₹226.49 Cr / ₹22.02 Cr) — the YoY jump is the real story, not the QoQ move. Standalone (parent-only) figures echo the trend: revenue ₹230.81 Cr (+84.8% YoY from ₹124.91 Cr) and PAT ₹23.87 Cr (+155.1% YoY from ₹9.36 Cr), EPS ₹1.57 versus ₹0.61. Neither statement carries exceptional items in either period, so the growth is fully operational rather than one-off-driven.

The margin expansion sits on the cost side, not pricing alone: consolidated OPM rose to 16.56% from 12.00% a year ago (and 15.75% last quarter), while NPM improved to 12.66% from 8.89% YoY. Employee benefit expense fell to 9.6% of revenue (from 15.7% YoY) and other expenses to 21.8% (from 27.7% YoY) as the much larger revenue base absorbed largely fixed costs — classic operating leverage — even as cost of materials consumed rose to 30.1% of revenue (from 13.8% YoY), consistent with higher throughput and raw-material pass-through in the extracts business.

The stock went into the print at ₹78.11, up 10.8% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.

Management has issued no formal guidance on record for this quarter, and no prior guidance exists in our records to grade this print against. A web search found no analyst consensus or brokerage preview for this small-cap (~₹1,081 Cr market cap), so the print cannot be benchmarked against street expectations — vsStreet is unknown rather than assumed. No management press release accompanied the results beyond the regulatory filing and auditor's review reports, so there is no company commentary to reconcile against the numbers. This quarter's other corporate developments — the FY26 BRSR filing, the 40th AGM scheduled for August 17, 2026, a June 9 director change, and the August 10 final-dividend record date — are routine governance/compliance items unconnected to this operating print. Auditors also flagged two smaller consolidated subsidiaries (combined revenue ~₹26.2 Cr, PAT ~₹0.35 Cr) as not independently reviewed and immaterial to the group.